Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults

Clinical Infectious Diseases

Volumn 34, Issue 11, 2002, Pages 1440-1448

  Grayson, M Lindsay ^a,b,d   McDonald, Malcolm ^e   Gibson, Kimberley ^b   Athan, Eugene ^e   Munckhof, Wendy J ^f   Paull, Phillip ^c   Chambers, Fran ^b,e  

^a Departments of Infectious Diseases   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e GEELONG HOSPITAL   (Australia)

^f Ipswich Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; PLACEBO; PROBENECID;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEFAZOLIN; CEFTRIAXONE; CELLULITIS; CEPHALOSPORINS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLACEBOS; PROBENECID; URICOSURIC AGENTS;

EID: 0036604380     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340056     Document Type: Article

References (26)

1. Cellulitis and subcutaneous tissue infections
2. Current and future management of serious skin and skin-structure infections
3. Association of athlete's foot with cellulitis of the lower extremities: Diagnostic value of bacterial cultures of ipsilateral interdigital space samples
4. Randomized comparison trial of teicoplanin i.v., teicoplanin i.m., and cefazolin therapy for skin and soft tissue infections caused by gram-positive bacteria
5. Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings
6. Once-daily ceftriaxone outpatient therapy in adults with infections
7. Outpatient parenteral antibiotic therapy: Management of serious infections. Part II. Amenable infections and models for delivery: Cellulitis
8. Once-daily ceftriaxone for skin and soft tissue infections
9. A comparative study of ceftriaxone vs. cefazolin in the treatment of cellulitis
10. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen
11. Treatment of cellulitis with twice-daily cefazolin via a home-based program
12. Effect of probenecid on cefazolin serum concentrations
13. Pharmacokinetics and pharmacodynamics of out-patient intravenous antimicrobial therapy
14. Sample preparation for chromatographic assays in the clinical laboratory
15. Antibiotics
16. Ceftriaxone versus cefazolin with probenecid for severe skin and soft tissue infections
17. Approaches to sample size estimation in the design of clinical trials - A review
18. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout
19. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections
20. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
21. The pharmacodynamics of β-lactams
22. Post-antibiotic effects in experimental infection models: Relationship to in-vitro phenomena and to treatment of infections in man